Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies
Abstract Phase I trials inform on the initial safety profile of a new molecule and impact whether further development is pursued or not. Understanding the effect of non‐pharmacological factors on the variability of routine safety parameters could improve decision making in these early clinical trial...
Saved in:
Main Authors: | Kelly E. Duncan (Author), Runcheng Li (Author), Lata Maganti (Author), Amit Kumar (Author), S. Aubrey Stoch (Author), Geoffrey A. Walford (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of pharmacokinetics, safety, and tolerability following twice‐daily administration of molnupiravir for 10 days in healthy participants
by: Marian Iwamoto, et al.
Published: (2023) -
A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19
by: Keisuke Nakamura, et al.
Published: (2022) -
The Pool in the Desert
by: Duncan, Sara Jeannette, 1861-1922 -
EFFICACY AND SAFETY OF INCLISIRAN BY BASELINE BODY MASS INDEX: A POST HOC POOLED ANALYSIS OF THE ORION-9, ORION-10 AND ORION-11 PHASE III RANDOMIZED CONTROLLED TRIALS
by: Lawrence A Leiter, et al.
Published: (2023) -
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis
by: Maria Garcia-Cremades, et al.
Published: (2022)